Global Recombinant Collagen Medical Aesthetic Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Page: 121

Published Date: 19 Jan 2024

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Recombinant Collagen Medical Aesthetic Injection market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

The Global Info Research report includes an overview of the development of the Recombinant Collagen Medical Aesthetic Injection industry chain, the market status of Hospital (Plant-derived Collagen, Animal-derived Collagen), Beauty Agency (Plant-derived Collagen, Animal-derived Collagen), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Recombinant Collagen Medical Aesthetic Injection.

Regionally, the report analyzes the Recombinant Collagen Medical Aesthetic Injection markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Recombinant Collagen Medical Aesthetic Injection market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Recombinant Collagen Medical Aesthetic Injection market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Recombinant Collagen Medical Aesthetic Injection industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Plant-derived Collagen, Animal-derived Collagen).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Recombinant Collagen Medical Aesthetic Injection market.

Regional Analysis: The report involves examining the Recombinant Collagen Medical Aesthetic Injection market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Recombinant Collagen Medical Aesthetic Injection market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Recombinant Collagen Medical Aesthetic Injection:
Company Analysis: Report covers individual Recombinant Collagen Medical Aesthetic Injection manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Recombinant Collagen Medical Aesthetic Injection This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Beauty Agency).

Technology Analysis: Report covers specific technologies relevant to Recombinant Collagen Medical Aesthetic Injection. It assesses the current state, advancements, and potential future developments in Recombinant Collagen Medical Aesthetic Injection areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Recombinant Collagen Medical Aesthetic Injection market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Recombinant Collagen Medical Aesthetic Injection market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
    Plant-derived Collagen
    Animal-derived Collagen

Market segment by Application
    Hospital
    Beauty Agency

Major players covered
    Nasvita Medical
    Mei Medica
    Hyamax
    Allergan Aesthetics
    CollPlant
    Giant Biogene Holding Co., Ltd
    Jinbo Bio
    Shuangmei Biotechnology Co., Ltd
    Bloomage Bio
    Changchun Botai Pharmaceutical Biotechnology Co., Ltd.

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Recombinant Collagen Medical Aesthetic Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Recombinant Collagen Medical Aesthetic Injection, with price, sales, revenue and global market share of Recombinant Collagen Medical Aesthetic Injection from 2019 to 2024.
Chapter 3, the Recombinant Collagen Medical Aesthetic Injection competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Recombinant Collagen Medical Aesthetic Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Recombinant Collagen Medical Aesthetic Injection market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Recombinant Collagen Medical Aesthetic Injection.
Chapter 14 and 15, to describe Recombinant Collagen Medical Aesthetic Injection sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Recombinant Collagen Medical Aesthetic Injection
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Recombinant Collagen Medical Aesthetic Injection Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Plant-derived Collagen
        1.3.3 Animal-derived Collagen
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Recombinant Collagen Medical Aesthetic Injection Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Hospital
        1.4.3 Beauty Agency
    1.5 Global Recombinant Collagen Medical Aesthetic Injection Market Size & Forecast
        1.5.1 Global Recombinant Collagen Medical Aesthetic Injection Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Recombinant Collagen Medical Aesthetic Injection Sales Quantity (2019-2030)
        1.5.3 Global Recombinant Collagen Medical Aesthetic Injection Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 Nasvita Medical
        2.1.1 Nasvita Medical Details
        2.1.2 Nasvita Medical Major Business
        2.1.3 Nasvita Medical Recombinant Collagen Medical Aesthetic Injection Product and Services
        2.1.4 Nasvita Medical Recombinant Collagen Medical Aesthetic Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Nasvita Medical Recent Developments/Updates
    2.2 Mei Medica
        2.2.1 Mei Medica Details
        2.2.2 Mei Medica Major Business
        2.2.3 Mei Medica Recombinant Collagen Medical Aesthetic Injection Product and Services
        2.2.4 Mei Medica Recombinant Collagen Medical Aesthetic Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Mei Medica Recent Developments/Updates
    2.3 Hyamax
        2.3.1 Hyamax Details
        2.3.2 Hyamax Major Business
        2.3.3 Hyamax Recombinant Collagen Medical Aesthetic Injection Product and Services
        2.3.4 Hyamax Recombinant Collagen Medical Aesthetic Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Hyamax Recent Developments/Updates
    2.4 Allergan Aesthetics
        2.4.1 Allergan Aesthetics Details
        2.4.2 Allergan Aesthetics Major Business
        2.4.3 Allergan Aesthetics Recombinant Collagen Medical Aesthetic Injection Product and Services
        2.4.4 Allergan Aesthetics Recombinant Collagen Medical Aesthetic Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Allergan Aesthetics Recent Developments/Updates
    2.5 CollPlant
        2.5.1 CollPlant Details
        2.5.2 CollPlant Major Business
        2.5.3 CollPlant Recombinant Collagen Medical Aesthetic Injection Product and Services
        2.5.4 CollPlant Recombinant Collagen Medical Aesthetic Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 CollPlant Recent Developments/Updates
    2.6 Giant Biogene Holding Co., Ltd
        2.6.1 Giant Biogene Holding Co., Ltd Details
        2.6.2 Giant Biogene Holding Co., Ltd Major Business
        2.6.3 Giant Biogene Holding Co., Ltd Recombinant Collagen Medical Aesthetic Injection Product and Services
        2.6.4 Giant Biogene Holding Co., Ltd Recombinant Collagen Medical Aesthetic Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Giant Biogene Holding Co., Ltd Recent Developments/Updates
    2.7 Jinbo Bio
        2.7.1 Jinbo Bio Details
        2.7.2 Jinbo Bio Major Business
        2.7.3 Jinbo Bio Recombinant Collagen Medical Aesthetic Injection Product and Services
        2.7.4 Jinbo Bio Recombinant Collagen Medical Aesthetic Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Jinbo Bio Recent Developments/Updates
    2.8 Shuangmei Biotechnology Co., Ltd
        2.8.1 Shuangmei Biotechnology Co., Ltd Details
        2.8.2 Shuangmei Biotechnology Co., Ltd Major Business
        2.8.3 Shuangmei Biotechnology Co., Ltd Recombinant Collagen Medical Aesthetic Injection Product and Services
        2.8.4 Shuangmei Biotechnology Co., Ltd Recombinant Collagen Medical Aesthetic Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Shuangmei Biotechnology Co., Ltd Recent Developments/Updates
    2.9 Bloomage Bio
        2.9.1 Bloomage Bio Details
        2.9.2 Bloomage Bio Major Business
        2.9.3 Bloomage Bio Recombinant Collagen Medical Aesthetic Injection Product and Services
        2.9.4 Bloomage Bio Recombinant Collagen Medical Aesthetic Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Bloomage Bio Recent Developments/Updates
    2.10 Changchun Botai Pharmaceutical Biotechnology Co., Ltd.
        2.10.1 Changchun Botai Pharmaceutical Biotechnology Co., Ltd. Details
        2.10.2 Changchun Botai Pharmaceutical Biotechnology Co., Ltd. Major Business
        2.10.3 Changchun Botai Pharmaceutical Biotechnology Co., Ltd. Recombinant Collagen Medical Aesthetic Injection Product and Services
        2.10.4 Changchun Botai Pharmaceutical Biotechnology Co., Ltd. Recombinant Collagen Medical Aesthetic Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Changchun Botai Pharmaceutical Biotechnology Co., Ltd. Recent Developments/Updates

3 Competitive Environment: Recombinant Collagen Medical Aesthetic Injection by Manufacturer
    3.1 Global Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Recombinant Collagen Medical Aesthetic Injection Revenue by Manufacturer (2019-2024)
    3.3 Global Recombinant Collagen Medical Aesthetic Injection Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Recombinant Collagen Medical Aesthetic Injection by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Recombinant Collagen Medical Aesthetic Injection Manufacturer Market Share in 2023
        3.4.2 Top 6 Recombinant Collagen Medical Aesthetic Injection Manufacturer Market Share in 2023
    3.5 Recombinant Collagen Medical Aesthetic Injection Market: Overall Company Footprint Analysis
        3.5.1 Recombinant Collagen Medical Aesthetic Injection Market: Region Footprint
        3.5.2 Recombinant Collagen Medical Aesthetic Injection Market: Company Product Type Footprint
        3.5.3 Recombinant Collagen Medical Aesthetic Injection Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Recombinant Collagen Medical Aesthetic Injection Market Size by Region
        4.1.1 Global Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Region (2019-2030)
        4.1.2 Global Recombinant Collagen Medical Aesthetic Injection Consumption Value by Region (2019-2030)
        4.1.3 Global Recombinant Collagen Medical Aesthetic Injection Average Price by Region (2019-2030)
    4.2 North America Recombinant Collagen Medical Aesthetic Injection Consumption Value (2019-2030)
    4.3 Europe Recombinant Collagen Medical Aesthetic Injection Consumption Value (2019-2030)
    4.4 Asia-Pacific Recombinant Collagen Medical Aesthetic Injection Consumption Value (2019-2030)
    4.5 South America Recombinant Collagen Medical Aesthetic Injection Consumption Value (2019-2030)
    4.6 Middle East and Africa Recombinant Collagen Medical Aesthetic Injection Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Type (2019-2030)
    5.2 Global Recombinant Collagen Medical Aesthetic Injection Consumption Value by Type (2019-2030)
    5.3 Global Recombinant Collagen Medical Aesthetic Injection Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Application (2019-2030)
    6.2 Global Recombinant Collagen Medical Aesthetic Injection Consumption Value by Application (2019-2030)
    6.3 Global Recombinant Collagen Medical Aesthetic Injection Average Price by Application (2019-2030)

7 North America
    7.1 North America Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Type (2019-2030)
    7.2 North America Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Application (2019-2030)
    7.3 North America Recombinant Collagen Medical Aesthetic Injection Market Size by Country
        7.3.1 North America Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Country (2019-2030)
        7.3.2 North America Recombinant Collagen Medical Aesthetic Injection Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Type (2019-2030)
    8.2 Europe Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Application (2019-2030)
    8.3 Europe Recombinant Collagen Medical Aesthetic Injection Market Size by Country
        8.3.1 Europe Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Country (2019-2030)
        8.3.2 Europe Recombinant Collagen Medical Aesthetic Injection Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Recombinant Collagen Medical Aesthetic Injection Market Size by Region
        9.3.1 Asia-Pacific Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Recombinant Collagen Medical Aesthetic Injection Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Type (2019-2030)
    10.2 South America Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Application (2019-2030)
    10.3 South America Recombinant Collagen Medical Aesthetic Injection Market Size by Country
        10.3.1 South America Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Country (2019-2030)
        10.3.2 South America Recombinant Collagen Medical Aesthetic Injection Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Recombinant Collagen Medical Aesthetic Injection Market Size by Country
        11.3.1 Middle East & Africa Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Recombinant Collagen Medical Aesthetic Injection Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Recombinant Collagen Medical Aesthetic Injection Market Drivers
    12.2 Recombinant Collagen Medical Aesthetic Injection Market Restraints
    12.3 Recombinant Collagen Medical Aesthetic Injection Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Recombinant Collagen Medical Aesthetic Injection and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Recombinant Collagen Medical Aesthetic Injection
    13.3 Recombinant Collagen Medical Aesthetic Injection Production Process
    13.4 Recombinant Collagen Medical Aesthetic Injection Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Recombinant Collagen Medical Aesthetic Injection Typical Distributors
    14.3 Recombinant Collagen Medical Aesthetic Injection Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Recombinant Collagen Medical Aesthetic Injection Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Recombinant Collagen Medical Aesthetic Injection Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Nasvita Medical Basic Information, Manufacturing Base and Competitors
    Table 4. Nasvita Medical Major Business
    Table 5. Nasvita Medical Recombinant Collagen Medical Aesthetic Injection Product and Services
    Table 6. Nasvita Medical Recombinant Collagen Medical Aesthetic Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 7. Nasvita Medical Recent Developments/Updates
    Table 8. Mei Medica Basic Information, Manufacturing Base and Competitors
    Table 9. Mei Medica Major Business
    Table 10. Mei Medica Recombinant Collagen Medical Aesthetic Injection Product and Services
    Table 11. Mei Medica Recombinant Collagen Medical Aesthetic Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 12. Mei Medica Recent Developments/Updates
    Table 13. Hyamax Basic Information, Manufacturing Base and Competitors
    Table 14. Hyamax Major Business
    Table 15. Hyamax Recombinant Collagen Medical Aesthetic Injection Product and Services
    Table 16. Hyamax Recombinant Collagen Medical Aesthetic Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 17. Hyamax Recent Developments/Updates
    Table 18. Allergan Aesthetics Basic Information, Manufacturing Base and Competitors
    Table 19. Allergan Aesthetics Major Business
    Table 20. Allergan Aesthetics Recombinant Collagen Medical Aesthetic Injection Product and Services
    Table 21. Allergan Aesthetics Recombinant Collagen Medical Aesthetic Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 22. Allergan Aesthetics Recent Developments/Updates
    Table 23. CollPlant Basic Information, Manufacturing Base and Competitors
    Table 24. CollPlant Major Business
    Table 25. CollPlant Recombinant Collagen Medical Aesthetic Injection Product and Services
    Table 26. CollPlant Recombinant Collagen Medical Aesthetic Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 27. CollPlant Recent Developments/Updates
    Table 28. Giant Biogene Holding Co., Ltd Basic Information, Manufacturing Base and Competitors
    Table 29. Giant Biogene Holding Co., Ltd Major Business
    Table 30. Giant Biogene Holding Co., Ltd Recombinant Collagen Medical Aesthetic Injection Product and Services
    Table 31. Giant Biogene Holding Co., Ltd Recombinant Collagen Medical Aesthetic Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 32. Giant Biogene Holding Co., Ltd Recent Developments/Updates
    Table 33. Jinbo Bio Basic Information, Manufacturing Base and Competitors
    Table 34. Jinbo Bio Major Business
    Table 35. Jinbo Bio Recombinant Collagen Medical Aesthetic Injection Product and Services
    Table 36. Jinbo Bio Recombinant Collagen Medical Aesthetic Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 37. Jinbo Bio Recent Developments/Updates
    Table 38. Shuangmei Biotechnology Co., Ltd Basic Information, Manufacturing Base and Competitors
    Table 39. Shuangmei Biotechnology Co., Ltd Major Business
    Table 40. Shuangmei Biotechnology Co., Ltd Recombinant Collagen Medical Aesthetic Injection Product and Services
    Table 41. Shuangmei Biotechnology Co., Ltd Recombinant Collagen Medical Aesthetic Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 42. Shuangmei Biotechnology Co., Ltd Recent Developments/Updates
    Table 43. Bloomage Bio Basic Information, Manufacturing Base and Competitors
    Table 44. Bloomage Bio Major Business
    Table 45. Bloomage Bio Recombinant Collagen Medical Aesthetic Injection Product and Services
    Table 46. Bloomage Bio Recombinant Collagen Medical Aesthetic Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 47. Bloomage Bio Recent Developments/Updates
    Table 48. Changchun Botai Pharmaceutical Biotechnology Co., Ltd. Basic Information, Manufacturing Base and Competitors
    Table 49. Changchun Botai Pharmaceutical Biotechnology Co., Ltd. Major Business
    Table 50. Changchun Botai Pharmaceutical Biotechnology Co., Ltd. Recombinant Collagen Medical Aesthetic Injection Product and Services
    Table 51. Changchun Botai Pharmaceutical Biotechnology Co., Ltd. Recombinant Collagen Medical Aesthetic Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 52. Changchun Botai Pharmaceutical Biotechnology Co., Ltd. Recent Developments/Updates
    Table 53. Global Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Manufacturer (2019-2024) & (K Units)
    Table 54. Global Recombinant Collagen Medical Aesthetic Injection Revenue by Manufacturer (2019-2024) & (USD Million)
    Table 55. Global Recombinant Collagen Medical Aesthetic Injection Average Price by Manufacturer (2019-2024) & (US$/Unit)
    Table 56. Market Position of Manufacturers in Recombinant Collagen Medical Aesthetic Injection, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
    Table 57. Head Office and Recombinant Collagen Medical Aesthetic Injection Production Site of Key Manufacturer
    Table 58. Recombinant Collagen Medical Aesthetic Injection Market: Company Product Type Footprint
    Table 59. Recombinant Collagen Medical Aesthetic Injection Market: Company Product Application Footprint
    Table 60. Recombinant Collagen Medical Aesthetic Injection New Market Entrants and Barriers to Market Entry
    Table 61. Recombinant Collagen Medical Aesthetic Injection Mergers, Acquisition, Agreements, and Collaborations
    Table 62. Global Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Region (2019-2024) & (K Units)
    Table 63. Global Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Region (2025-2030) & (K Units)
    Table 64. Global Recombinant Collagen Medical Aesthetic Injection Consumption Value by Region (2019-2024) & (USD Million)
    Table 65. Global Recombinant Collagen Medical Aesthetic Injection Consumption Value by Region (2025-2030) & (USD Million)
    Table 66. Global Recombinant Collagen Medical Aesthetic Injection Average Price by Region (2019-2024) & (US$/Unit)
    Table 67. Global Recombinant Collagen Medical Aesthetic Injection Average Price by Region (2025-2030) & (US$/Unit)
    Table 68. Global Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Type (2019-2024) & (K Units)
    Table 69. Global Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Type (2025-2030) & (K Units)
    Table 70. Global Recombinant Collagen Medical Aesthetic Injection Consumption Value by Type (2019-2024) & (USD Million)
    Table 71. Global Recombinant Collagen Medical Aesthetic Injection Consumption Value by Type (2025-2030) & (USD Million)
    Table 72. Global Recombinant Collagen Medical Aesthetic Injection Average Price by Type (2019-2024) & (US$/Unit)
    Table 73. Global Recombinant Collagen Medical Aesthetic Injection Average Price by Type (2025-2030) & (US$/Unit)
    Table 74. Global Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Application (2019-2024) & (K Units)
    Table 75. Global Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Application (2025-2030) & (K Units)
    Table 76. Global Recombinant Collagen Medical Aesthetic Injection Consumption Value by Application (2019-2024) & (USD Million)
    Table 77. Global Recombinant Collagen Medical Aesthetic Injection Consumption Value by Application (2025-2030) & (USD Million)
    Table 78. Global Recombinant Collagen Medical Aesthetic Injection Average Price by Application (2019-2024) & (US$/Unit)
    Table 79. Global Recombinant Collagen Medical Aesthetic Injection Average Price by Application (2025-2030) & (US$/Unit)
    Table 80. North America Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Type (2019-2024) & (K Units)
    Table 81. North America Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Type (2025-2030) & (K Units)
    Table 82. North America Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Application (2019-2024) & (K Units)
    Table 83. North America Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Application (2025-2030) & (K Units)
    Table 84. North America Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Country (2019-2024) & (K Units)
    Table 85. North America Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Country (2025-2030) & (K Units)
    Table 86. North America Recombinant Collagen Medical Aesthetic Injection Consumption Value by Country (2019-2024) & (USD Million)
    Table 87. North America Recombinant Collagen Medical Aesthetic Injection Consumption Value by Country (2025-2030) & (USD Million)
    Table 88. Europe Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Type (2019-2024) & (K Units)
    Table 89. Europe Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Type (2025-2030) & (K Units)
    Table 90. Europe Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Application (2019-2024) & (K Units)
    Table 91. Europe Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Application (2025-2030) & (K Units)
    Table 92. Europe Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Country (2019-2024) & (K Units)
    Table 93. Europe Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Country (2025-2030) & (K Units)
    Table 94. Europe Recombinant Collagen Medical Aesthetic Injection Consumption Value by Country (2019-2024) & (USD Million)
    Table 95. Europe Recombinant Collagen Medical Aesthetic Injection Consumption Value by Country (2025-2030) & (USD Million)
    Table 96. Asia-Pacific Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Type (2019-2024) & (K Units)
    Table 97. Asia-Pacific Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Type (2025-2030) & (K Units)
    Table 98. Asia-Pacific Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Application (2019-2024) & (K Units)
    Table 99. Asia-Pacific Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Application (2025-2030) & (K Units)
    Table 100. Asia-Pacific Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Region (2019-2024) & (K Units)
    Table 101. Asia-Pacific Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Region (2025-2030) & (K Units)
    Table 102. Asia-Pacific Recombinant Collagen Medical Aesthetic Injection Consumption Value by Region (2019-2024) & (USD Million)
    Table 103. Asia-Pacific Recombinant Collagen Medical Aesthetic Injection Consumption Value by Region (2025-2030) & (USD Million)
    Table 104. South America Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Type (2019-2024) & (K Units)
    Table 105. South America Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Type (2025-2030) & (K Units)
    Table 106. South America Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Application (2019-2024) & (K Units)
    Table 107. South America Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Application (2025-2030) & (K Units)
    Table 108. South America Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Country (2019-2024) & (K Units)
    Table 109. South America Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Country (2025-2030) & (K Units)
    Table 110. South America Recombinant Collagen Medical Aesthetic Injection Consumption Value by Country (2019-2024) & (USD Million)
    Table 111. South America Recombinant Collagen Medical Aesthetic Injection Consumption Value by Country (2025-2030) & (USD Million)
    Table 112. Middle East & Africa Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Type (2019-2024) & (K Units)
    Table 113. Middle East & Africa Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Type (2025-2030) & (K Units)
    Table 114. Middle East & Africa Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Application (2019-2024) & (K Units)
    Table 115. Middle East & Africa Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Application (2025-2030) & (K Units)
    Table 116. Middle East & Africa Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Region (2019-2024) & (K Units)
    Table 117. Middle East & Africa Recombinant Collagen Medical Aesthetic Injection Sales Quantity by Region (2025-2030) & (K Units)
    Table 118. Middle East & Africa Recombinant Collagen Medical Aesthetic Injection Consumption Value by Region (2019-2024) & (USD Million)
    Table 119. Middle East & Africa Recombinant Collagen Medical Aesthetic Injection Consumption Value by Region (2025-2030) & (USD Million)
    Table 120. Recombinant Collagen Medical Aesthetic Injection Raw Material
    Table 121. Key Manufacturers of Recombinant Collagen Medical Aesthetic Injection Raw Materials
    Table 122. Recombinant Collagen Medical Aesthetic Injection Typical Distributors
    Table 123. Recombinant Collagen Medical Aesthetic Injection Typical Customers
List of Figures
    Figure 1. Recombinant Collagen Medical Aesthetic Injection Picture
    Figure 2. Global Recombinant Collagen Medical Aesthetic Injection Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Recombinant Collagen Medical Aesthetic Injection Consumption Value Market Share by Type in 2023
    Figure 4. Plant-derived Collagen Examples
    Figure 5. Animal-derived Collagen Examples
    Figure 6. Global Recombinant Collagen Medical Aesthetic Injection Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 7. Global Recombinant Collagen Medical Aesthetic Injection Consumption Value Market Share by Application in 2023
    Figure 8. Hospital Examples
    Figure 9. Beauty Agency Examples
    Figure 10. Global Recombinant Collagen Medical Aesthetic Injection Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 11. Global Recombinant Collagen Medical Aesthetic Injection Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 12. Global Recombinant Collagen Medical Aesthetic Injection Sales Quantity (2019-2030) & (K Units)
    Figure 13. Global Recombinant Collagen Medical Aesthetic Injection Average Price (2019-2030) & (US$/Unit)
    Figure 14. Global Recombinant Collagen Medical Aesthetic Injection Sales Quantity Market Share by Manufacturer in 2023
    Figure 15. Global Recombinant Collagen Medical Aesthetic Injection Consumption Value Market Share by Manufacturer in 2023
    Figure 16. Producer Shipments of Recombinant Collagen Medical Aesthetic Injection by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
    Figure 17. Top 3 Recombinant Collagen Medical Aesthetic Injection Manufacturer (Consumption Value) Market Share in 2023
    Figure 18. Top 6 Recombinant Collagen Medical Aesthetic Injection Manufacturer (Consumption Value) Market Share in 2023
    Figure 19. Global Recombinant Collagen Medical Aesthetic Injection Sales Quantity Market Share by Region (2019-2030)
    Figure 20. Global Recombinant Collagen Medical Aesthetic Injection Consumption Value Market Share by Region (2019-2030)
    Figure 21. North America Recombinant Collagen Medical Aesthetic Injection Consumption Value (2019-2030) & (USD Million)
    Figure 22. Europe Recombinant Collagen Medical Aesthetic Injection Consumption Value (2019-2030) & (USD Million)
    Figure 23. Asia-Pacific Recombinant Collagen Medical Aesthetic Injection Consumption Value (2019-2030) & (USD Million)
    Figure 24. South America Recombinant Collagen Medical Aesthetic Injection Consumption Value (2019-2030) & (USD Million)
    Figure 25. Middle East & Africa Recombinant Collagen Medical Aesthetic Injection Consumption Value (2019-2030) & (USD Million)
    Figure 26. Global Recombinant Collagen Medical Aesthetic Injection Sales Quantity Market Share by Type (2019-2030)
    Figure 27. Global Recombinant Collagen Medical Aesthetic Injection Consumption Value Market Share by Type (2019-2030)
    Figure 28. Global Recombinant Collagen Medical Aesthetic Injection Average Price by Type (2019-2030) & (US$/Unit)
    Figure 29. Global Recombinant Collagen Medical Aesthetic Injection Sales Quantity Market Share by Application (2019-2030)
    Figure 30. Global Recombinant Collagen Medical Aesthetic Injection Consumption Value Market Share by Application (2019-2030)
    Figure 31. Global Recombinant Collagen Medical Aesthetic Injection Average Price by Application (2019-2030) & (US$/Unit)
    Figure 32. North America Recombinant Collagen Medical Aesthetic Injection Sales Quantity Market Share by Type (2019-2030)
    Figure 33. North America Recombinant Collagen Medical Aesthetic Injection Sales Quantity Market Share by Application (2019-2030)
    Figure 34. North America Recombinant Collagen Medical Aesthetic Injection Sales Quantity Market Share by Country (2019-2030)
    Figure 35. North America Recombinant Collagen Medical Aesthetic Injection Consumption Value Market Share by Country (2019-2030)
    Figure 36. United States Recombinant Collagen Medical Aesthetic Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 37. Canada Recombinant Collagen Medical Aesthetic Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 38. Mexico Recombinant Collagen Medical Aesthetic Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 39. Europe Recombinant Collagen Medical Aesthetic Injection Sales Quantity Market Share by Type (2019-2030)
    Figure 40. Europe Recombinant Collagen Medical Aesthetic Injection Sales Quantity Market Share by Application (2019-2030)
    Figure 41. Europe Recombinant Collagen Medical Aesthetic Injection Sales Quantity Market Share by Country (2019-2030)
    Figure 42. Europe Recombinant Collagen Medical Aesthetic Injection Consumption Value Market Share by Country (2019-2030)
    Figure 43. Germany Recombinant Collagen Medical Aesthetic Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 44. France Recombinant Collagen Medical Aesthetic Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 45. United Kingdom Recombinant Collagen Medical Aesthetic Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 46. Russia Recombinant Collagen Medical Aesthetic Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 47. Italy Recombinant Collagen Medical Aesthetic Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 48. Asia-Pacific Recombinant Collagen Medical Aesthetic Injection Sales Quantity Market Share by Type (2019-2030)
    Figure 49. Asia-Pacific Recombinant Collagen Medical Aesthetic Injection Sales Quantity Market Share by Application (2019-2030)
    Figure 50. Asia-Pacific Recombinant Collagen Medical Aesthetic Injection Sales Quantity Market Share by Region (2019-2030)
    Figure 51. Asia-Pacific Recombinant Collagen Medical Aesthetic Injection Consumption Value Market Share by Region (2019-2030)
    Figure 52. China Recombinant Collagen Medical Aesthetic Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 53. Japan Recombinant Collagen Medical Aesthetic Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 54. Korea Recombinant Collagen Medical Aesthetic Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 55. India Recombinant Collagen Medical Aesthetic Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 56. Southeast Asia Recombinant Collagen Medical Aesthetic Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 57. Australia Recombinant Collagen Medical Aesthetic Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 58. South America Recombinant Collagen Medical Aesthetic Injection Sales Quantity Market Share by Type (2019-2030)
    Figure 59. South America Recombinant Collagen Medical Aesthetic Injection Sales Quantity Market Share by Application (2019-2030)
    Figure 60. South America Recombinant Collagen Medical Aesthetic Injection Sales Quantity Market Share by Country (2019-2030)
    Figure 61. South America Recombinant Collagen Medical Aesthetic Injection Consumption Value Market Share by Country (2019-2030)
    Figure 62. Brazil Recombinant Collagen Medical Aesthetic Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 63. Argentina Recombinant Collagen Medical Aesthetic Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 64. Middle East & Africa Recombinant Collagen Medical Aesthetic Injection Sales Quantity Market Share by Type (2019-2030)
    Figure 65. Middle East & Africa Recombinant Collagen Medical Aesthetic Injection Sales Quantity Market Share by Application (2019-2030)
    Figure 66. Middle East & Africa Recombinant Collagen Medical Aesthetic Injection Sales Quantity Market Share by Region (2019-2030)
    Figure 67. Middle East & Africa Recombinant Collagen Medical Aesthetic Injection Consumption Value Market Share by Region (2019-2030)
    Figure 68. Turkey Recombinant Collagen Medical Aesthetic Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 69. Egypt Recombinant Collagen Medical Aesthetic Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 70. Saudi Arabia Recombinant Collagen Medical Aesthetic Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 71. South Africa Recombinant Collagen Medical Aesthetic Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 72. Recombinant Collagen Medical Aesthetic Injection Market Drivers
    Figure 73. Recombinant Collagen Medical Aesthetic Injection Market Restraints
    Figure 74. Recombinant Collagen Medical Aesthetic Injection Market Trends
    Figure 75. Porters Five Forces Analysis
    Figure 76. Manufacturing Cost Structure Analysis of Recombinant Collagen Medical Aesthetic Injection in 2023
    Figure 77. Manufacturing Process Analysis of Recombinant Collagen Medical Aesthetic Injection
    Figure 78. Recombinant Collagen Medical Aesthetic Injection Industrial Chain
    Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 80. Direct Channel Pros & Cons
    Figure 81. Indirect Channel Pros & Cons
    Figure 82. Methodology
    Figure 83. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Nasvita Medical
Mei Medica
Hyamax
Allergan Aesthetics
CollPlant
Giant Biogene Holding Co., Ltd
Jinbo Bio
Shuangmei Biotechnology Co., Ltd
Bloomage Bio
Changchun Botai Pharmaceutical Biotechnology Co., Ltd.

Related Reports

Global Recombinant Collagen Medical Aesthetic Injection Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Recombinant Collagen Medical Aesthetic Injection Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 10 Sep 2023

date Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Recombinant Collagen Medical Aesthetic Injection market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.

Global Recombinant Collagen Medical Aesthetic Injection Supply, Demand and Key Producers, 2023-2029

Global Recombinant Collagen Medical Aesthetic Injection Supply, Demand and Key Producers, 2023-2029

date 10 Sep 2023

date Medical Devices & Consumables

The global Recombinant Collagen Medical Aesthetic Injection market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Product Tags

Recombinant Collagen Medical Aesthetic Injection

Blood Plasma Refrigerator

ENT Camera System

Medical Repair Titanium Mesh

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>